Drug Profile
Filgrastim biosimilar - CT Arzneimittel
Alternative Names: Biograstim (CT Arzneimittel)Latest Information Update: 12 Nov 2021
Price :
$50
*
At a glance
- Originator CT Arzneimittel
- Class Chemoprotectants; Granulocyte colony-stimulating factors; Neuroprotectants; Recombinant proteins
- Mechanism of Action Granulocyte colony stimulating factor receptor agonists; Granulocyte colony-stimulating factor replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Neutropenia
Most Recent Events
- 16 May 2016 Launched for Neutropenia in Slovakia and Lithuania (IV), (SC) before May 2016
- 04 Apr 2011 Launched for Neutropenia in Germany, Ireland, Netherlands, Poland, Portugal and Czech Republic (IV, infusion) after September 2008
- 04 Apr 2011 Launched for Neutropenia in Germany, Ireland, Netherlands, Poland, Portugal and Czech Republic (SC, injection) after September 2008